. Author manuscript; available in PMC: 2015 Feb 19.

Published in final edited form as: J Urol. 2014 Apr 18;192(3):730–735. doi: 10.1016/j.juro.2014.04.017

Table 2.

Screening and biopsy results in 1,037 healthy men in Accra, Ghana

	Age Group

	Overall	50–59	60–69	70–74
No. pos DRE	154	53	56	45
No. PSA 2.5 ng/ml or greater group:	272	72	123	77
Pos DRE with/without PSA 2.5 ng/ml or greater	352	112	149	91
Biopsy	307	98	132	77
Prostate Ca/total No. screened (%)	73/1,037 (7.03)^*	19/507 (3.72)	27/374 (7.22)	27/156 (17.26)
No. PSA 4.0 ng/ml or greater group:	166	42	75	49
Pos DRE with/without PSA 4.0 ng/ml or greater	264	85	109	70
Biopsy	237	75	101	61
Prostate Ca/total No. screened (%)	65/1,037 (6.26)^†	16/507 (3.12)	23/374 (6.15)	26/156 (16.66)

Crude and age adjusted prevalence 7.0% and 6.6%, respectively.

^†

Crude and age adjusted prevalence 6.3% and 5.8%, respectively.